MS in Organic Chemistry from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences; Bachelor of Engineering in Pharmaceutical Engineering from China Pharmaceutical University

Over 10 years of experience in biopharma R&D and investment. Over 30 investment cases with proven track record. 

VP, YuanBio Venture Capital

Analyst, YuanBio Venture Capital

Medicinal Chemistry Researcher, Basilea Pharmaceutica Ltd.

Kintor Pharma (9939.HK), BrightGene (688166), Allist Pharma (688578), Kawin Technology (688687), ShengNuo Biotech (688117), Ascentage Pharma (6855.HK), Smartee, ATKC, SHIP, Arkbio, Pegbio, Sunvou, etc.